Unbuzzd Wellness Prepares for Potential IPO with New Auditor Appointment
Quantum BioPharma's portfolio company Unbuzzd Wellness Inc. has appointed MNP LLP as its new auditor and completed a name change, signaling strategic preparations for a potential public listing and capital raising efforts.
Unbuzzd Wellness Inc., a portfolio company of Quantum BioPharma, has taken significant steps toward potential public market entry by appointing MNP LLP as its new PCAOB auditor. The company, formerly known as Celly Nutrition Corp., completed a formal name change on May 23, 2025, which will not impact existing shareholder rights or share certificates.
The auditor appointment follows the resignation of Stern & Lovrics LLP and aligns with the company's previously announced plans from February 2025 to engage a New York investment bank for capital raising and public listing advisory services. This strategic move suggests Unbuzzd Wellness is positioning itself for increased financial transparency and potential investor scrutiny.
The appointment comes at a critical time for the company, which has developed the scientifically backed unbuzzd™ beverage. By selecting a reputable auditing firm and preparing comprehensive financial documentation, Unbuzzd Wellness is demonstrating its commitment to meeting the rigorous standards required for potential initial public offering (IPO) consideration.
Quantum BioPharma, which retains 25.71% ownership of Unbuzzd Wellness, stands to benefit from the company's strategic developments. The partnership includes a royalty agreement where Quantum BioPharma will receive 7% of sales until payments total $250 million, after which the royalty will decrease to 3% in perpetuity.